Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study - Lavery, A; Stevenson, L; McManus, D; Logan, GE; Walker, SM; Jellema, GL; Van Schaeybroeck, S; Virdee, PS; Middleton, MR; Elhussein, L; Turbitt, J; Colinson, D; et al. (Journal of Clinical Oncology, 2020)